Assess lung sounds,pulse, BP beforeadmin and duringpeak of med. Noteamount, color, andcharacter of sputumproduced.Monitor forhypokalemia asalbuterol maycause a decreasein serumpotassiumonset iswithin 3to 4hrDo not draw up dose into asyringe from the kiwi pens,syringe markings do notmatch up and could lead tomedication error. Prior towithdrawing dose, rotatevial btw palms to ensureuniform solution; do notshae.hypoglycemia,hypokalemia,erythema,lipodystrophy,pruritus,swelling.Antidiabetics,rapid actinginsulinspancreaticAssess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.Treatment&prevention ofbronchospasmin asthma andCOPD.chest pain,palpitations,nervousness,restlessness, tremor,paradoxicalbronchospasmw/excessive use.Explain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.Stimulate glucoseuptake in skeletalmuscle and fat,inhibit hepaticglucoseproduction.NovologInform pts of unusualbad taste. Advise ptsto rinse mouth aftereach inhalation tominimize dry mouth.antidiabetic,long-actinginsulinonset iswithin15minMonitor pulmonaryfunction testbefore initiatingtherapy andperiodically duringtherapy.SCBronchodilators;adrenergicInstruct pts on propertechniques for admin.Demonstratetechnique for mixinginsulins by drawingup insulin Aspart first.Observe forparadoxicalbronchospasm(wheezing). NotifyHCP immediately ifcondition occurs.controlhyperglycemiain pts withT1/T2 DM.Basaglar,Lantus,ToujouCaution pt not toexceedrecommended dose,may cause adverseeffects or loss ofeffectiveness of med.Administersubq within 5-10min beforemeal. Rotateinjection sites.Administer oralmed with mealsto minimizegastric irritationBinds to beta 2 adrenergicreceptors in airway smoothmuscle by inhibitingphosphorylation of myosinand decrease intracellularcalcium leads to relaxationof smooth muscle airways.AlbuterolSulfate Instruct ptsto contactHCPimmediatelyof SOB.PO/inhalationInsulinGlargineDo not mix insulinGlargine with otherinsulin. If giving witha short acting insulin,use separatesyringes and diffinjection sites.InsulinApartAssess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.Shake inhaler welland allow at least1min btw inhalations.Prime inhaler beforefirst use by releasing4 test sprays.Explain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.Assess lung sounds,pulse, BP beforeadmin and duringpeak of med. Noteamount, color, andcharacter of sputumproduced.Monitor forhypokalemia asalbuterol maycause a decreasein serumpotassiumonset iswithin 3to 4hrDo not draw up dose into asyringe from the kiwi pens,syringe markings do notmatch up and could lead tomedication error. Prior towithdrawing dose, rotatevial btw palms to ensureuniform solution; do notshae.hypoglycemia,hypokalemia,erythema,lipodystrophy,pruritus,swelling.Antidiabetics,rapid actinginsulinspancreaticAssess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.Treatment&prevention ofbronchospasmin asthma andCOPD.chest pain,palpitations,nervousness,restlessness, tremor,paradoxicalbronchospasmw/excessive use.Explain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.Stimulate glucoseuptake in skeletalmuscle and fat,inhibit hepaticglucoseproduction.NovologInform pts of unusualbad taste. Advise ptsto rinse mouth aftereach inhalation tominimize dry mouth.antidiabetic,long-actinginsulinonset iswithin15minMonitor pulmonaryfunction testbefore initiatingtherapy andperiodically duringtherapy.SCBronchodilators;adrenergicInstruct pts on propertechniques for admin.Demonstratetechnique for mixinginsulins by drawingup insulin Aspart first.Observe forparadoxicalbronchospasm(wheezing). NotifyHCP immediately ifcondition occurs.controlhyperglycemiain pts withT1/T2 DM.Basaglar,Lantus,ToujouCaution pt not toexceedrecommended dose,may cause adverseeffects or loss ofeffectiveness of med.Administersubq within 5-10min beforemeal. Rotateinjection sites.Administer oralmed with mealsto minimizegastric irritationBinds to beta 2 adrenergicreceptors in airway smoothmuscle by inhibitingphosphorylation of myosinand decrease intracellularcalcium leads to relaxationof smooth muscle airways.AlbuterolSulfate Instruct ptsto contactHCPimmediatelyof SOB.PO/inhalationInsulinGlargineDo not mix insulinGlargine with otherinsulin. If giving witha short acting insulin,use separatesyringes and diffinjection sites.InsulinApartAssess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.Shake inhaler welland allow at least1min btw inhalations.Prime inhaler beforefirst use by releasing4 test sprays.Explain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
  1. Assess lung sounds, pulse, BP before admin and during peak of med. Note amount, color, and character of sputum produced.
  2. Monitor for hypokalemia as albuterol may cause a decrease in serum potassium
  3. onset is within 3 to 4hr
  4. Do not draw up dose into a syringe from the kiwi pens, syringe markings do not match up and could lead to medication error. Prior to withdrawing dose, rotate vial btw palms to ensure uniform solution; do not shae.
  5. hypoglycemia, hypokalemia, erythema, lipodystrophy, pruritus, swelling.
  6. Antidiabetics, rapid acting insulins
  7. pancreatic
  8. Assess for symptoms of hypoglycemia. Monitor body weight periodically. Assess pts for signs of allergic rxn. Monitor glucose q6h during therapy. Monitor serum K+ in pts at risk for hypokalemia.
  9. Treatment &prevention of bronchospasm in asthma and COPD.
  10. chest pain, palpitations, nervousness, restlessness, tremor, paradoxical bronchospasm w/excessive use.
  11. Explain to pts that this med controls hyperglycemia but does not cure diabetes, therapy is long term. Pts w/DM should carry a source of sugar.
  12. Stimulate glucose uptake in skeletal muscle and fat, inhibit hepatic glucose production.
  13. Novolog
  14. Inform pts of unusual bad taste. Advise pts to rinse mouth after each inhalation to minimize dry mouth.
  15. antidiabetic, long-acting insulin
  16. onset is within 15min
  17. Monitor pulmonary function test before initiating therapy and periodically during therapy.
  18. SC
  19. Bronchodilators; adrenergic
  20. Instruct pts on proper techniques for admin. Demonstrate technique for mixing insulins by drawing up insulin Aspart first.
  21. Observe for paradoxical bronchospasm (wheezing). Notify HCP immediately if condition occurs.
  22. control hyperglycemia in pts with T1/T2 DM.
  23. Basaglar, Lantus, Toujou
  24. Caution pt not to exceed recommended dose, may cause adverse effects or loss of effectiveness of med.
  25. Administer subq within 5-10min before meal. Rotate injection sites.
  26. Administer oral med with meals to minimize gastric irritation
  27. Binds to beta 2 adrenergic receptors in airway smooth muscle by inhibiting phosphorylation of myosin and decrease intracellular calcium leads to relaxation of smooth muscle airways.
  28. Albuterol Sulfate
  29. Instruct pts to contact HCP immediately of SOB.
  30. PO/inhalation
  31. Insulin Glargine
  32. Do not mix insulin Glargine with other insulin. If giving with a short acting insulin, use separate syringes and diff injection sites.
  33. Insulin Apart
  34. Assess for symptoms of hypoglycemia. Monitor body weight periodically. Assess pts for signs of allergic rxn. Monitor glucose q6h during therapy. Monitor serum K+ in pts at risk for hypokalemia.
  35. Shake inhaler well and allow at least 1min btw inhalations. Prime inhaler before first use by releasing 4 test sprays.
  36. Explain to pts that this med controls hyperglycemia but does not cure diabetes, therapy is long term. Pts w/DM should carry a source of sugar.